Clinical Trial Update: A Study With Darapladib to Collect Tolerability Information [Phase 1]

View source ↗

Summary

Phase 1 trial update for darapladib to collect tolerability data in patients with atherosclerosis; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis

Drugs mentioned

• Darapladib (darapladib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Atherosclerosis | Phase 1 | Status: COMPLETED